Jack Zaremba
Internal Medicine · Birmingham, ALNPI 1104918309
Payments from drug & device makers
Across 217 payments — averaging $15.60 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Johnson & Johnson$609
- AstraZeneca$430
- Amarin Pharma, Inc.$383
- Novo Nordisk$341
- Qiagen, LLC$242
- Pfizer$233
- plus $1K from 18 others
What the payments were for
- Food & beverage$3,374100%
- Education$120%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Johnson & Johnson | 38 | $609 |
| AstraZeneca | 33 | $430 |
| Amarin Pharma, Inc. | 25 | $383 |
| Novo Nordisk | 24 | $341 |
| Qiagen, LLC | 2 | $242 |
| Pfizer | 20 | $233 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 10 | $162 |
| Astellas Pharma US Inc | 8 | $120 |
| Lilly USA, LLC | 8 | $107 |
| Amgen | 6 | $99 |
| Merck | 6 | $92 |
| Esperion Therapeutics, Inc. | 5 | $89 |
| Boehringer Ingelheim | 5 | $79 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $69 |
| E.r. Squibb & Sons, L.L.C. | 5 | $69 |
| GSK | 5 | $67 |
| Sanofi-aventis U.S. LLC | 2 | $39 |
| Eisai Inc. | 3 | $36 |
| Kowa Pharmaceuticals America, Inc. | 3 | $34 |
| AbbVie | 2 | $24 |
| Abbott | 1 | $19 |
| Boston Scientific | 1 | $15 |
| Teva Pharmaceuticals USA, Inc. | 1 | $14 |
| Mannkind Corporation | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- AUTOMATION - QIASTAT$227
How this compares
$3,386 in reported general payments places this provider in the 75th percentile of 1,533 internal medicine providers in Alabama.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Gemfibrozil | 13 | $28 |
Paid to pharmacies, not to this prescriber.
Other internal medicine in Birmingham
- David DeatkineBirmingham$8M
- James SullivanBirmingham$6M
- Ramy TomaBirmingham$5.1M
- William KirbyBirmingham$2.3M
- Jordan VaughnBirmingham$1.6M
- Stefanie KrickBirmingham$527K
- Ryan WeldonBirmingham$458K
- Ashraf KhanBirmingham$215K
- Robert LewisBirmingham$201K
- David WynneBirmingham$180K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.